How did the COVID-19 pandemic impact AMETEK's financial performance in 2020?

The COVID-19 pandemic negatively impacted AMETEK's business in 2020, leading to a 12.0% decrease in net sales to $4.54 billion. This was primarily due to a 13% organic sales decline attributed to a weak global economy. The company incurred $43.9 million in realignment costs to address these challenges. Despite the sales decline, AMETEK achieved record EBITDA and free cash flow, demonstrating resilience.

What is AMETEK's strategy for growth?

AMETEK's growth strategy is driven by the "AMETEK Growth Model," which integrates four key strategies: Operational Excellence, Strategic Acquisitions, Global and Market Expansion, and New Product Development. The company focuses on cash generation and capital deployment, with a primary focus on strategic, value-enhancing acquisitions.

What are AMETEK's key operating segments?

AMETEK operates through two primary groups: Electronic Instruments (EIG), which designs and manufactures advanced instruments for process, power and industrial, and aerospace markets; and Electromechanical (EMG), which supplies precision motion control solutions, thermal management systems, specialty metals, and electrical interconnects for aerospace and defense, medical, and automation markets.

How does AMETEK manage its debt and capital structure?

AMETEK has a robust credit facility and actively manages its debt. At December 31, 2020, the company had $2.41 billion in total debt and a debt-to-capital ratio of 28.9%. The net debt-to-capital ratio was a healthy 16.8%. The company also repurchased shares and increased its quarterly cash dividend, indicating a balanced approach to capital deployment.

AME 10-K FY2020 Annual Report — Revenue, Net Income, EPS

Summary

AMETEK, Inc. (AME) reported its fiscal year 2020 results, showcasing resilience amidst the COVID-19 pandemic. The company experienced a decrease in net sales by 12.0% to $4.54 billion, primarily due to a 13% organic sales decline driven by pandemic-related economic weakness. Despite this, AMETEK achieved record EBITDA of $1.42 billion and record free cash flow of $1.21 billion, demonstrating strong operational execution and working capital management. The company successfully navigated the challenging environment through its "Operational Excellence" initiatives and strategic acquisitions, including IntelliPower and the completion of acquisition accounting for Gatan. AMETEK also divested its Reading Alloys business, contributing to a significant pre-tax gain. The company's diversified business model across Electronic Instruments (EIG) and Electromechanical (EMG) groups, serving various end markets like aerospace, defense, medical, and industrial automation, provided stability.

Financial Highlights

55 data points

Beta

Revenue

$4.54B

0.3% Gross Margin

Net Income

$872.44M

0.2% Net Margin

EPS (Diluted)

$3.77

Total Assets

$10.36B

Cash & Equivalents

$1.21B

Free Cash Flow

$1.21B

Financial Statements

Beta

Revenue	$4.54B
Cost of Revenue	$3.00B
Gross Profit	$1.54B
R&D Expenses	$158.90M
SG&A Expenses	$515.63M
Operating Expenses	$3.51B
Operating Income	$1.03B
Interest Expense	$86.06M
Net Income	$872.44M
EPS (Basic)	$3.80
EPS (Diluted)	$3.77
Shares Outstanding (Basic)	229.44M
Shares Outstanding (Diluted)	231.15M

Key Highlights

1Net sales decreased by 12.0% to $4.54 billion, impacted by the COVID-19 pandemic's economic effects.
2Achieved record EBITDA of $1.42 billion, indicating strong profitability.
3Generated record free cash flow of $1.21 billion, highlighting efficient cash generation.
4Successfully integrated acquisitions like IntelliPower and Gatan, contributing to future growth potential.
5Divested the Reading Alloys business, resulting in a significant pre-tax gain of $141 million.
6Maintained strong operational discipline and implemented realignment costs totaling $43.9 million to mitigate pandemic impacts.
7Continued investment in R&D, with sales from products introduced in the last three years representing 23.7% of net sales.

AMETEK INC/ Annual Report, Year Ended Dec 31, 2020

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions